These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1688267)

  • 1. Effect of sulphasalazine in patients with juvenile chronic arthritis (JCA).
    Settas L; Alexiou P; Dimitriadis G; Mata-Tsi E; Souliou E; Papapanagiotou J; Tourkantonis A
    Acta Univ Carol Med (Praha); 1991; 37(1-2):76-9. PubMed ID: 1688267
    [No Abstract]   [Full Text] [Related]  

  • 2. Sulfasalazine treatment in juvenile chronic arthritis: an open study.
    Joos R; Veys EM; Mielants H; van Werveke S; Goemaere S
    J Rheumatol; 1991 Jun; 18(6):880-4. PubMed ID: 1680193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulphasalazine in the treatment of juvenile rheumatoid arthritis: a preliminary open trial.
    Ozdogan H; Turunç M; Deringöl B; Yurdakul S; Yazici H
    J Rheumatol; 1986 Feb; 13(1):124-5. PubMed ID: 2871188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sulfasalazine in the treatment of chronic juvenile arthritis].
    Hoza J; Havelka S; Kadlecová T; Nĕmcová D
    Cesk Pediatr; 1989 Oct; 44(10):601-3. PubMed ID: 2575932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double-blind, placebo-controlled, multicenter study. Dutch Juvenile Chronic Arthritis Study Group.
    van Rossum MA; Fiselier TJ; Franssen MJ; Zwinderman AH; ten Cate R; van Suijlekom-Smit LW; van Luijk WH; van Soesbergen RM; Wulffraat NM; Oostveen JC; Kuis W; Dijkstra PF; van Ede CF; Dijkmans BA
    Arthritis Rheum; 1998 May; 41(5):808-16. PubMed ID: 9588731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of juvenile chronic arthritis with sulfasalazine].
    Suschke HJ
    Z Rheumatol; 1987; 46(2):83-5. PubMed ID: 2885990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulphasalazine and Delagil--a comparative study in patients with juvenile chronic arthritis.
    Hoza J; Kadlecová T; Nĕmcová D; Havelka S
    Acta Univ Carol Med (Praha); 1991; 37(1-2):80-3. PubMed ID: 1688268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of juvenile spondylarthritis and reactive arthritis with sulfasalazine].
    Suschke HJ
    Monatsschr Kinderheilkd; 1992 Sep; 140(9):658-60. PubMed ID: 1359405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of juvenile spondyloarthropathies with sulfasalazine].
    Job-Deslandre C; Menkès CJ
    Rev Rhum Ed Fr; 1993; 60(7-8):489-91. PubMed ID: 7908584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulphasalazine. An alternative drug for second-line treatment of juvenile chronic arthritis.
    Varbanova BB; Dyankov ED
    Adv Exp Med Biol; 1999; 455():331-6. PubMed ID: 10599365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfasalazine for the management of juvenile rheumatoid arthritis.
    Brooks CD
    J Rheumatol; 2001 Apr; 28(4):845-53. PubMed ID: 11327261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of n-3 fatty acids in chronic juvenile arthritis].
    Alpigiani MG; Ravera G; Buzzanca C; Devescovi R; Fiore P; Iester A
    Pediatr Med Chir; 1996; 18(4):387-90. PubMed ID: 9064671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulfasalazine in juvenile rheumatoid arthritis.
    Dülgeroğlu M
    J Rheumatol; 1988; 15(5):881. PubMed ID: 2902223
    [No Abstract]   [Full Text] [Related]  

  • 14. [The clinical feature, diagnosis and treatment of uveitis associated with juvenile chronic arthritis].
    Zhang Z; Yang PZ; Zhou HY; Yu Q; Huang XK; Li B
    Zhonghua Yan Ke Za Zhi; 2005 Apr; 41(4):346-9. PubMed ID: 15924698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicentre pilot study of sulphasalazine in juvenile chronic arthritis.
    Ansell BM; Hall MA; Loftus JK; Woo P; Neumann V; Harvey A; Sills JA; Swinson D; Insley J; Amos R
    Clin Exp Rheumatol; 1991; 9(2):201-3. PubMed ID: 1676352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of patients with juvenile chronic arthritis and juvenile spondyloarthropathy.
    Minden K; Kiessling U; Listing J; Niewerth M; Döring E; Meincke J; Schöntube M; Zink A
    J Rheumatol; 2000 Sep; 27(9):2256-63. PubMed ID: 10990244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A subgroup-specific evaluation of the efficacy of intraarticular triamcinolone hexacetonide in juvenile chronic arthritis.
    Breit W; Frosch M; Meyer U; Heinecke A; Ganser G
    J Rheumatol; 2000 Nov; 27(11):2696-702. PubMed ID: 11093456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug treatment in juvenile chronic arthritis].
    Goldenstein-Schainberg C; Yoshinari NH
    Rev Hosp Clin Fac Med Sao Paulo; 1997; 52(2):90-5. PubMed ID: 9435402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Juvenile chronic arthritis--bone mineral density in relation to corticosteroid therapy.
    Bayer M; Stĕpán J; Nĕmcová D; Kutílek S; Hoza J
    Acta Univ Carol Med (Praha); 1994; 40(1-4):33-5. PubMed ID: 9355669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemophagocytic syndrome occurring in polyarticular juvenile arthritis treated by salazopyrine].
    Bouayed K; Brik H; Zakari A; Mikou N; Dehbi F
    Arch Pediatr; 2006 Aug; 13(8):1156-7. PubMed ID: 16793243
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.